Working… Menu
Trial record 1 of 1 for:    NCT03635983
Previous Study | Return to List | Next Study

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03635983
Recruitment Status : Recruiting
First Posted : August 17, 2018
Last Update Posted : November 17, 2020
Nektar Therapeutics
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 25, 2022
Estimated Study Completion Date : June 16, 2025